Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGILENT TECHNOLOGIES, INC.A · Entity 3062 | Sr Vice President | March 29, 2018 | March 29, 2018 |
| BECTON DICKINSON & COBDX · Entity 2498 | EVP & Pres Life Sciences | November 26, 2020 | November 30, 2020 |
| METTLER TOLEDO INTERNATIONAL INC/MTD · Entity 3168 | President and CEO | August 27, 2026 | August 31, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGILENT TECHNOLOGIES, INC.
Report date March 29, 2018 · Filed March 29, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 68,547.467 |
Ending reported balance
After 2018-03-29 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-03-29 · Exercise / conversion · Acquired 4,000 · Balance 72,547.467 Row 2 · 2018-03-29 · Sale · Disposed 4,000 · Balance 68,547.467 |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.26 · Expires 2024-11-19 | Direct | 11,292 |
Reported balance
After 2018-03-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-03-29 · Exercise / conversion · Disposed 4,000 · Balance 11,292 F1: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3. F2: The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated. |
Filing footnotes · ownership attribution and instrument terms
F1: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3.
F2: The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated.
BECTON DICKINSON & CO
Report date November 26, 2020 · Filed November 30, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Rights to Common Stock Under BD Deferred Compensation PlanSEC Table II · derivative / convertible security | Direct | 621 |
Reported balance
After 2020-11-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-11-26 · Grant · Acquired 621 · Balance 621 F1: The securities convert to common stock on a one-for-one basis. F2: The securities are distributed following termination of the reporting person's servicer, or on the date or dates specified by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities convert to common stock on a one-for-one basis.
F2: The securities are distributed following termination of the reporting person's servicer, or on the date or dates specified by the reporting person.
METTLER TOLEDO INTERNATIONAL INC/
Report date August 27, 2026 · Filed August 31, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 4,480 |
Ending reported balance
After 2026-08-27 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-27 · Exercise / conversion · Acquired 942 · Balance 5,422 Row 2 · 2026-08-27 · Sale · Disposed 942 · Balance 4,480 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1,024.55 · Expires 2033-11-09 | Direct | 4,413 |
Reported balance
After 2026-08-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-27 · Exercise / conversion · Disposed 942 · Balance 4,413 F1: The options vest annually in five equal installments beginning on the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest annually in five equal installments beginning on the first anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2017 Filed Feb 21, 2017 18:32 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionCommon Stock | 3,771 | $26.19 | $98,762.49 |
DisclosureSEC source: 0001127602-17-007249 · form4.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · Sr Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,903.494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 6.226 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 21:55 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 17,270 | $46.18 | $797,528.60 |
DisclosureSEC source: 0001127602-16-067781 · form4.xml · nonDerivative · entry 3 Kaltenbach Patrick · CIK 0001625775 · Sr Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,126.048 F3 · shares: Restricted Stock Units granted under the Agilent Technologies, Inc. 2009 Stock Plan, in compliance with Rule 16b-3. The restricted stock units vest in four equal annual installments beginning on November 16, 2017. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 21:55 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 123 | $46.18 | $5,680.14 |
DisclosureSEC source: 0001127602-16-067781 · form4.xml · nonDerivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · Sr Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,856.048 F2 · shares: The reporting person surrendered 123 shares to Agilent Technologies, Inc. to satisfy tax liability on the issuance of shares in accordance with Rule 16b-3. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 21:55 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 2,516 | $46.18 | $116,188.88 |
DisclosureSEC source: 0001127602-16-067781 · form4.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · Sr Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,979.048 F1 · shares: On November 16, 2016, 2,516 shares of common stock of Agilent Technologies, Inc. were issued to the reporting person pursuant to the Agilent Technologies, Inc. Long-Term Performance Program of which 2,390 shares were deferred pursuant to the Agilent Technologies, Inc. Deferred Compensation Plan. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 21:05 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $26.19 | $0.00 |
DisclosureSEC source: 0001127602-16-063704 · form4.xml · derivative · entry 3 Kaltenbach Patrick · CIK 0001625775 · Sr Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,771 Underlying: Common Stock · 2,000 shares Expires 2022-11-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3. F2 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 21:05 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | SaleCommon Stock | 2,000 | $47.30 | $94,600.00 |
DisclosureSEC source: 0001127602-16-063704 · form4.xml · nonDerivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · Sr Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,463.048 Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 21:05 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionCommon Stock | 2,000 | $26.19 | $52,380.00 |
DisclosureSEC source: 0001127602-16-063704 · form4.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · Sr Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,463.048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.